Eslicarbazepine Acetate - CAS 236395-14-5
Catalog number:
236395-14-5
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
COA:
Inquire
Targets:
Others
Description:
Eslicarbazepine acetate, (BIA 2-093), is a promising antiepileptic drug structurally related to Carbamazepine and Oxcarbazepine.
Publictions citing BOC Sciences Products
  • >> More
Purity:
0.98
Synonyms:
(10S)-10-(Acetyloxy)-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide; (S)-(-)-10-Acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide; BIA 2-093; Sep 0002093;
MSDS:
Inquire
1. Voltage-gated sodium channel blockers, 2001-2006: An overview
Hedvig Bolcskei, Istvan Tarnawa, Pa l Kocsis. Med Chem Res (2008) 17:356–368
A traditional therapeutic area of VGSC blockers is epilepsy. Phenytoin derivatives (e.g., phosphenytoin) should be mentioned first. Carbamazepine and its derivatives are also widely used antiepileptics (e.g., oxcarbazepine, licarbazepine, eslicarbazepine, and eslicarbazepine acetate). Eslicarbazepine is the optically active isomer of licarbazepine (Fig. 1). Amitryptiline (Fig. 1), just like other tricyclic antidepressants, is effective against various pain syndromes, and blocks sodium channels. Various diphenylamineanalogues were prepared by Hudgens and co-workers. A structure–activityrelationship (SAR) study among them revealed that the tricyclic moiety is not essential for hNaV1.2 activity (Hudgens et al., 2006).
2. Recent and Emerging Anti-seizure Drugs: 2013
William O. Tatum, DO. Current Treatment Options in Neurology (2013) 15:505-518
Eslicarbazepine acetate (Esli) is a prodrug that was approved in the US in 2012 as Zebinix® (Exalief® in Europe). It is activated to eslicarbazepine (S-licarbazepine), an active metabolite of oxcarbazepine. It is indicated in the treatment of adults with focal seizures with/without generalization. Esli is a pro-drug that is rapidly metabolized by hydrolysis almost exclusively to S-licarbazepine. It blocks voltage-gated sodium channels. However in comparison, Esli has a lower affinity for the sodium channel in the resting state and preferentially blocks rapidly firing neurons during the inactive state. It has a bioavailability that is approximately 94 % of the parent dose and a half-life of 20–24 hours. It has linear pharmacokinetics and is metabolized without the formation of an epoxide intermediary and Esli does not undergo autoinduction. It may be reduced by enzymeinducing ASDs (EIASDs), but does not affect other ASDs and is primarily excreted by the kidney.
3. Newer Antiepileptic Drugs: Evidence Based Use
Gouri Rao Passi. Indian J Pediatr (October 2014) 81(10):1042–1051
There are many newer molecules in the pipeline with novel mechanisms of action which will need more pediatric data such as lacosamide, ezogabine, eslicarbamazepine, perampenel and brivaracetam. Lacosamide selectively enhances slow inactivation of voltage-gated sodium channels which reduces the ability of (epileptic) neurons to sustain prolonged firing bursts and may mediate neuronal plasticity which holds the hint of inhibiting epileptogenesis. It has been known to cause suicidal ideation and conduction blocks. However, it has not yet been cleared for use below 17 y. Ezogabine has a different mechanism of action (K channel opener) and inhibits smooth muscle contractility, which has raised concerns about its effect on bladder function. Eslicarbazepine acetate displays a greater affinity for the inactive state (already fired) of the sodium channel rather than the resting state (waiting to fire), meaning that it could be more selective for rapidly firing neurons. Perampenel is approved only above 12 y of age for partial onset epilepsy. It acts as a non competitive inhibitor of the AMPA glutamate receptor. It has a boxed warning of severe neuropsychiatric side effects. Brivaracetam has 13 times higher affinity for the synaptic vesicle protein 2A than levetiracetam and also inhibits sodium channels. It has orphan drug status for symptomatic myoclonus.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 58186-27-9 Idebenone

Idebenone
(CAS: 58186-27-9)

Idebenone is a synthetic analog of coenzyme Q10 (CoQ10) and a brain stimulant.

CAS 115-67-3 paramethadione

paramethadione
(CAS: 115-67-3)

This active molecular is an an antiepileptic and anticonvulsant agent. It is associated with fetal trimethadione syndrome that is also called as paramethadione ...

CAS 22457-89-2 Benfotiamine

Benfotiamine
(CAS: 22457-89-2)

Benfotiamine is an amphiphilic S-acyl thiamine derivative used as a lipid soluble alternative source of bioavailable thiamine. Benfotiamine is being investigate...

GSK-1071306
(CAS: 1252927-47-1)

GSK-1071306 is one of the metabolites of pazopanib which is a inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity as a approve...

CAS 52286-59-6 Ginsenoside Re

Ginsenoside Re
(CAS: 52286-59-6)

Ginsenoside Re, extracted from the traditional Chinese herb ginseng, responsible for some of the pharmacological functions.

BMS-210285
(CAS: 344607-69-8)

BMS-210285 is a synthetic bio-active chemical.

GNE-3500
(CAS: 1537859-24-7)

GNE-3500 has been found to be a Retinoic acid receptor-related Orphan receptor C agonist that could be probably significant in studies of some inflammatory dise...

CAS 88105-29-7 Notoginseng folium saponins

Notoginseng folium saponins
(CAS: 88105-29-7)

Notoginsenoside Fe is a natural compound isolated from the roots of Panax notoginseng.

CAS 83461-56-7 Mifamurtide

Mifamurtide
(CAS: 83461-56-7)

Mifamurtide is a liposomal formulation containing a muramyl dipeptide (MDP) analogue with potential immunomodulatory and antineoplastic activities. It is a deri...

CAS 484-12-8 Osthole

Osthole
(CAS: 484-12-8)

Osthol is an is a calcium channel blocker, which is found in the plants such as Cnidium monnieri, Angelica archangelica and Angelica pubescens.

CAS 1416992-39-6 GC376

GC376
(CAS: 1416992-39-6)

GC376 is a 3CLpro inhibitor which is previously reported to be active against the 3CLpro of multiple coronaviruses, including SARS-CoV, but with highest potency...

CAS 223445-75-8 Atagabalin

Atagabalin
(CAS: 223445-75-8)

Atagabalin, also referred to PD-0200,390, is a gabamimetic agent developed as a treatment for insomnia but was discontinued following unsatisfactory trial resul...

CAS 5534-95-2 Pentagastrin

Pentagastrin
(CAS: 5534-95-2)

Pentagastrin is a synthetic polypeptide used as a diagnostic aid for evaluation of gastric acid secretory function

CAS 100-51-6 Benzyl alcohol

Benzyl alcohol
(CAS: 100-51-6)

Benzyl alcohol, an aromatic alcohol compound, could be found in many sorts of essential oils with the FEMA number: 2137.

Ritobegron ethyl hydrochloride
(CAS: 476333-91-2)

Ritobegron is a potential Bladder selectivity of the novel β₃-agonist.

GNE-495
(CAS: 1449277-10-4)

GNE-495 is a Selective MAP4K4 (Mitogen-activated protein kinase kinase kinase kinase 4) Inhibitor. IC50 value is 3.7 nM. GNE-495 shows excellent potency and goo...

CAS 4754-39-6 Deoxyadenosine

Deoxyadenosine
(CAS: 4754-39-6)

Deoxyadenosine is a substrate of bacterial methylthioadenosine/S-adenosylhomocysteine (MTA/SAH) nucleosidase and a product inhibitor produced by radical SAM enz...

CAS 35543-24-9 Buflomedil Hydrochloride

Buflomedil Hydrochloride
(CAS: 35543-24-9)

Buflomedil HCl is a vasodilator used to treat claudication or the symptoms of peripheral arterial disease.

CAS 129639-79-8 abafungin

abafungin
(CAS: 129639-79-8)

Abafungin is a broad-spectrum antifungal agent with a novel mechanism of action originated by York Pharma. In Aug 2009, Phase-III for Dermatomycoses in Japan an...

CAS 90098-04-7 Rebamipide

Rebamipide
(CAS: 90098-04-7)

Rebamipide has been shown to enhance mucosal defense by scavenging free radicals, and temporarily activating genes encoding cyclooxygenase-2.

Chemical Structure

CAS 236395-14-5 Eslicarbazepine Acetate

Quick Inquiry

Verification code

Featured Items